Monday, September 11, 2017
AngioDynamics Announces Pricing of Secondary Offering by Selling Stockholders
ALBANY, N.Y. , Nov. 14, 2016 (GLOBE NEWSWIRE) -- AngioDynamics, Inc. (NASDAQ:ANGO) (the "Company"), a leading provider of innovative, minimally invasive medical devices for vascular access, surgery, peripheral vascular disease and oncology, today announced the pricing of the previously announced...

  Monday, September 11, 2017
AngioDynamics Announces Secondary Offering of 2,500,000 Shares of Common Stock by Selling Stockholders
ALBANY, N.Y. , Nov. 14, 2016 (GLOBE NEWSWIRE) -- AngioDynamics, Inc. (NASDAQ:ANGO) (the "Company"), a leading provider of innovative, minimally invasive medical devices for vascular access, surgery, peripheral vascular disease and oncology, today announced that certain of its stockholders (the...

  Monday, September 11, 2017
AngioDynamics Announces New Senior Credit Facilities and New Share Repurchase Program
New Senior Credit Facility Includes a $100 Million TLA and a $150 Million RCF Board of Directors Authorizes Up to $25 Million in Share Repurchases ALBANY, N.Y. , Nov. 09, 2016 (GLOBE NEWSWIRE) -- AngioDynamics (NASDAQ:ANGO), a leading provider of innovative, minimally invasive medical devices for...

  Monday, September 11, 2017
AngioDynamics Announces Addition of New Board Members: Eileen Auen, Former Executive Chairman of Helios and Jan Stern Reed, Former General Counsel and Corporate Secretary at Walgreens Boots Alliance, Inc.
ALBANY, N.Y. , Nov. 09, 2016 (GLOBE NEWSWIRE) -- AngioDynamics (NASDAQ:ANGO), a leading provider of innovative, minimally invasive medical devices for vascular access, surgery, peripheral vascular disease and oncology, today announced the appointment of Eileen Auen and Jan Stern Reed to the...

  Monday, September 11, 2017
AngioDynamics to Present at the 2016 Canaccord Genuity Medical Technologies and Diagnostics Forum
ALBANY, N.Y. , Nov. 07, 2016 (GLOBE NEWSWIRE) -- AngioDynamics (NASDAQ:ANGO), a leading provider of innovative, minimally invasive medical devices for vascular access, surgery, peripheral vascular disease and oncology, announced today that Jim Clemmer , President and Chief Executive Officer, is...

  Monday, September 11, 2017
AngioDynamics Reports Fiscal 2017 First Quarter Results
Q1 net sales of $88.1 million , up 5% year-over-year Q1 GAAP earnings per share of $0.04 ; non-GAAP adjusted EPS of $0.17 Q1 operating cash generation of $7.4 million FY2017 guidance remains unchanged ALBANY, N.Y. , Oct. 05, 2016 (GLOBE NEWSWIRE) -- AngioDynamics (NASDAQ:ANGO), a leading provider...

  Monday, September 11, 2017
AngioDynamics to Report Fiscal 2017 First Quarter Financial Results
ALBANY, N.Y. , Sept. 21, 2016 (GLOBE NEWSWIRE) -- AngioDynamics  (NASDAQ:ANGO), a leading provider of innovative, minimally invasive medical devices for vascular access, surgery, peripheral vascular disease and oncology, today announced it will report financial results for its fiscal 2017 first...

  Monday, September 11, 2017
AngioDynamics to Present at the 2016 Morgan Stanley Global Healthcare Conference
ALBANY, N.Y. , Sept. 06, 2016 (GLOBE NEWSWIRE) -- AngioDynamics (NASDAQ:ANGO), a leading provider of innovative, minimally invasive medical devices for vascular access, surgery, peripheral vascular disease and oncology, announced today that Jim Clemmer , President and Chief Executive Officer, is...

  Monday, September 11, 2017
AngioDynamics to Present at the 2016 Canaccord Genuity Growth Conference
ALBANY, N.Y. , Aug. 08, 2016 (GLOBE NEWSWIRE) -- AngioDynamics (NASDAQ:ANGO), a leading provider of innovative, minimally invasive medical devices for vascular access, surgery, peripheral vascular disease and oncology, announced today that Jim Clemmer , President and Chief Executive Officer, is...

  Monday, September 11, 2017
AngioDynamics Announces Secondary Offering of 2,250,000 Shares of Common Stock by Selling Stockholders
ALBANY, N.Y. , Aug. 01, 2016 (GLOBE NEWSWIRE) -- AngioDynamics, Inc. (NASDAQ:ANGO), a leading provider of innovative, minimally invasive medical devices for vascular access, surgery, peripheral vascular disease and oncology, today announced that Avista Capital Partners, LP and affiliated investment...

  Monday, September 11, 2017
AngioDynamics Issues Statement Regarding Stryker recall of Angiographic Catheters
AngioDynamics Issues Statement Regarding Stryker recall of Angiographic Catheters   ALBANY, N.Y., July 27, 2016 -- AngioDynamics (NASDAQ:ANGO), a leading provider of innovative, minimally invasive medical devices for vascular access, surgery, peripheral vascular disease and oncology, issued...

  Monday, September 11, 2017
AngioDynamics Appoints Michael C. Greiner as New Chief Financial Officer
Greiner brings more than 20 years of accounting, corporate finance and operations experience from a variety of global corporations...

  Monday, September 11, 2017
AngioDynamics Reports Fiscal 2016 Fourth Quarter and Full Year Results
Q4 Net sales of $93.4 million , up 3% year-over-year Q4 GAAP loss per share of $1.21 , inclusive of a one-time tax asset write down of $40.1 million ; Non-GAAP adjusted EPS of $0.19 , up 37% year-over-year Q4 Operating cash generation of $18.5 million FY2017 revenue guidance set at $355-$360...

  Monday, September 11, 2017
AngioDynamics to Report Fiscal 2016 Fourth Quarter and Full Year Financial Results
ALBANY, N.Y. , June 29, 2016 (GLOBE NEWSWIRE) -- AngioDynamics (NASDAQ:ANGO), a leading provider of innovative, minimally invasive medical devices for vascular access, surgery, peripheral vascular disease and oncology, today announced it will report financial results for its fiscal 2016 fourth...

  Monday, September 11, 2017
AngioDynamics Reports Fiscal 2016 Third Quarter Results
Net sales of $87.4 million , up 1% year-over-year GAAP earnings per share of $0.02 ; Non-GAAP adjusted EPS of $0.15 , up 25% year-over-year Operating cash generation of $12.4 million FY2016 financial guidance updated   ALBANY, N.Y. , April 07, 2016 (GLOBE NEWSWIRE) -- AngioDynamics (NASDAQ:ANGO), a...